Citadel Advisors
BNR

Citadel Advisors’s Burning Rock Biotech BNR Stock Holding History

Citadel Advisors’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Buy
27,288
+9,619
+54% +$136K ﹤0.01% 11674
2026
Q1 		$285K Buy
+17,669
New +$463K ﹤0.01% 10585
2025
Q3 		– Sell
-24,451
Closed -$77.3K – 12794
2025
Q2 		$77.3K Buy
+24,451
New +$75.9K ﹤0.01% 11519
2025
Q1 		– Sell
-12,267
Closed -$82.8K – 14512
2024
Q4 		$82.8K Buy
+12,267
New +$56.5K ﹤0.01% 11746
2024
Q2 		– Sell
-1,256
Closed -$9.16K – 14286
2024
Q1 		$9.16K Buy
+1,256
New +$10.5K ﹤0.01% 13517
2022
Q4 		– Sell
-2,601
Closed -$63K – 14883
2022
Q3 		$63K Buy
+2,601
New +$83.9K ﹤0.01% 11456
2022
Q2 		– Sell
-2,875
Closed -$267K – 12908
2022
Q1 		$267K Sell
2,875
-12,185
-81% -$1.06M ﹤0.01% 10849
2021
Q4 		$1.44M Buy
15,060
+11,729
+352% +$1.61M ﹤0.01% 6987
2021
Q3 		$596K Sell
3,331
-487
-13% -$108K ﹤0.01% 9432
2021
Q2 		$1.13M Sell
3,818
-6,780
-64% -$2.01M ﹤0.01% 8058
2021
Q1 		$2.85M Buy
+10,598
New +$3.23M ﹤0.01% 5560
2020
Q3 		– Sell
-2,000
Closed -$540K – 10084
2020
Q2 		$540K Buy
+2,000
New +$548K ﹤0.01% 6933

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
CL
CRCM LP San Francisco, California $152M AUM 26.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AIP
Almanack Investment Partners Wayne, Pennsylvania $785M AUM 34.37% 1-Year Est. Return

Citadel Advisors's BNR Position: Q2 2026 in Review

Citadel Advisors increased its Burning Rock Biotech (BNR) stake by 54% in Q2 2026, buying an estimated $136K and bringing the position to 27,288 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #11674.

Citadel Advisors first reported a position in BNR in Q2 2020 and has held it in 12 quarters since. The position peaked at $2.85M in Q1 2021. 17 funds tracked by Wall St. Rank hold BNR as of Q2 2026.

  • Citadel Advisors held 27,288 shares of Burning Rock Biotech worth $237K as of Q2 2026.
  • Citadel Advisors bought 9,619 Burning Rock Biotech shares in Q2 2026, an estimated $136K.
  • Burning Rock Biotech made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11674 holding.
  • Citadel Advisors first reported a position in Burning Rock Biotech in Q2 2020 and has held it in 12 quarters since.
  • Citadel Advisors's Burning Rock Biotech position peaked at $2.85M in Q1 2021.
  • 17 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.